Encompass Health Corporation beat EPS estimates 94% of the time across 16 reported quarters (15 beats, 1 misses), averaging +12.3% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $1.48 | $1.55 | +4.7% | Beat | |
| Q1 FY26 | $1.51 | $1.60 | +6.0% | Beat | |
| Q4 FY25 | $1.29 | $1.46 | +13.2% | Beat | Q4 FY25 call |
| Q3 FY25 | $1.19 | $1.23 | +3.4% | Beat | |
| Q2 FY25 | $1.20 | $1.40 | +16.7% | Beat | Q2 FY25 call |
| Q1 FY25 | $1.19 | $1.37 | +15.1% | Beat | Q1 FY25 call |
| Q4 FY24 | $1.02 | $1.17 | +14.7% | Beat | |
| Q3 FY24 | $0.94 | $1.03 | +9.6% | Beat | |
| Q2 FY24 | $1.01 | $1.11 | +9.9% | Beat | |
| Q1 FY24 | $0.93 | $1.12 | +20.4% | Beat | |
| Q4 FY23 | $0.83 | $0.95 | +14.5% | Beat | |
| Q3 FY23 | $0.77 | $0.86 | +11.7% | Beat |
Back to EHC overview · EHC holders · EHC KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.